Applications published 14 January 2009

• Device for the controlled release of a substance and method of releasing a substance
Koninklijke Philips Electronics 2012748*

• Pharmaceutical compsn containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof
I.Q.A 2012749*

• Methods for coacervation induced liposomal encapsulation and formulations thereof
Transave 2012750*

• Novel nanoparticles for delivery of active agents
Morehouse School of Medicine 2012751*

• Use of polymeric materials with other substances for improved performance
Gelesis 2012752*

• Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0]hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
Schering 2012753*

• Oral rapid release pharmaceutical formulation for pyrimidyl-methylsulphinyl-benzimidazoles
Mepha 2012754*

• Niosom-hydrogel drug delivery
University of South Florida 2012755*

• Multiple unit compsns
Thermis Laboratories 2012756*

• Asymmetric membranes for drug delivery devices
Pfizer Products 2010757*

• Inhibitors of the TASK-1 and TASK-3 ion channel
Sanofi-Aventis Deutschland 2012758*

• Purine derivatives as A2A receptor agonists
Novartis 2012759*

• Purine derivatives for use as adenosin A2A receptor agonists
Novartis 2012760*

• Statins for the treatment of viral influenza infections
Prendergast, Patrick 2012761*

• Intranasal administration of ketamine to treat depression
Mount Sinai School of Medicine; The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services; Yale University 2102762*

• Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an NSAID
Grünenthal 2012763*

• Compsns and methods useful for treatment of respiratory illness
Procter & Gamble 2012765*